Archive for the ‘Previous Events’ Category

You are here: Home » Previous Events » "

Join us at 7th Oncology Biomarkers, San Diego between 19th and 21st March. CEO Mohammad Afshar will be speaking at 5pm on 20th March on the following: 'Optimal Treatment Selection Tools and Real-time Diagnostics: Towards Multi Component Signature Predictive Software Systems.' Through the media of scientific presentations, case studies and panel discussions, the conference will bring together experts in the oncology biomarker research field to explore and discuss latest developments.  

Read more

Join us at Big DIP, London between 18th and 20th February to hear from leading Big Data experts- what the 4Vs of Big Data (volume, variety, velocity and veracity) mean for R&D and the marketing of drugs in 2014. Our VP of Computational Technology, Dave Morley will be presenting on the topic 'Improve Clinical Data Analysis to Aid Drug Discovery using Big Data'.

Read more

Meet applications scientist Lilia Abtroun at the Techinnov B2B Innovation Meetings in Orly, Paris on the 13th February. Now in it's 8th year, Techinnov is an event dedicated to technology and innovation and will feature the following; business meetings, biotech meetings, R&D meetings, funding meetings, flash presentations, and workshops.

Read more

Ariana Pharma and Voisin Life Sciences Consulting present a conference in Boston on November 12th addressing the topic: Product Development 'What the FDA's Innovative Initiatives enable' Modern approaches for managing the complexity of product development Ariana Pharma and Voisin Consulting Life Science are happy to host a seminar by Frederico Goodsaid, PhD - VP, Strategic Regulatory Intelligence at Vertex Pharmaceuticals and Antoinette Paone, MS - Sr Director, Head of Regulatory Affairs CMC at Vertex, who will discuss in detail the story of the development of Kalydeco. This presentation will be hosted by Mohammad Afshar, CEO of Ariana, and Mark A. De Rosch, PhD - VP, regulatory Drugs/ Biologics at Voisin. Please note that attendance to this conference is by invitation only. If you would like to join us, please contact Chad Mills.

Read more